08-31-2023
HKD/share | |
Price | 12.90 |
Dividend | 0.66 |
Earnings | 1.77 |
Cash-flow | 1.39 |
Book value | 18.43 |
Equity | 17.02 |
Shanghai Pharmaceuti is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Shanghai Pharmaceuti is a company from China, and his stocks are publicly traded.
Shanghai Pharmaceuti stock dividend
Shanghai Pharmaceuti paid a total dividend of 607 million HKD last year, for a market value of 11,855 millions (Market Cap 10,825 millions). Shanghai Pharmaceuti dividend per share is 0.66 HKD, and his stock market price 12.90 HKD.
According to the chart below, where dividend yield is displayed, Shanghai Pharmaceuti has a dividend yield of 5.15%, which is higher than the amount offered by both the market average and companies from China. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.
In addition, you should compare Shanghai Pharmaceuti stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the high China dividend stocks list.
Shanghai Pharmaceuti Dividend Payout
About the ability of Shanghai Pharmaceuti to maintain his current dividend of HKD 0.66 per share, an amount that accounts for 5.15%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Shanghai Pharmaceuti payout on ernings is currently 37.29%, which is lower than the market average, but higher than companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures show that Shanghai Pharmaceuti is in a good position to keep maintaining his dividend.
The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Shanghai Pharmaceuti is HKD 1.39 per share, which is higher than the dividend per share paid by the company of HKD 0.66, so the company generates enough cash to maintain his dividend in the future.
The following figure shows payout ratios over earnings and cashflow of Shanghai Pharmaceuti, compared againt world market average, China companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
Shanghai Pharmaceuti Dividend History
Below you will find a table with the historical evolution of Shanghai Pharmaceuti's dividend stock, both in percentage and in HKD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).
Year | Yield | HKD | Paypout | Shares* |
Present | 5.15% | 0.66 | 37.29% | 919 |
2022 | 3.79% | 0.49 | 28.99% | 919 |
2021 | 3.90% | 0.58 | 27.10% | 919 |
2020 | 3.52% | 0.48 | 25.67% | 919 |
2019 | 3.08% | 0.47 | 28.48% | 919 |
2018 | 2.90% | 0.46 | 35.38% | 919 |
2017 | 1.95% | 0.41 | 27.33% | 766 |
2016 | 2.00% | 0.39 | 35.14% | 766 |
2015 | 2.06% | 0.35 | 32.41% | 766 |
*In millions
Then you can see the evolution of Shanghai Pharmaceuti dividend stock, and compare it with the average of China stocks and that of the Pharmaceuticals and Biotechnology stocks.
Shanghai Pharmaceuti Stock performance
Finally, last moth Shanghai Pharmaceuti showed a return of -8.60% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a 12.80% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for China and Pharmaceuticals and Biotechnology firms.